By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Adaptimmune Ltd. 

57c Milton Park

Abingdon  Oxfordshire  OX14 4RX  United Kingdom
Phone: +44-(0)-1235-438-642 Fax: +44-(0)-1235-438-607


Key Statistics

Ownership: Public

Web Site: Adaptimmune
Symbol: ADAP

Company News
GlaxoSmithKline (GSK) Bets Another $500 Million on Adaptimmune (ADAP)'s Clinical Cancer Program 2/2/2016 11:24:11 AM
Adaptimmune (ADAP) Expands T-Cell Engineering Expertise To Develop Affinity Enhanced T-Cell Therapies For Autoimmune Indications 1/7/2016 8:48:17 AM
Adaptimmune (ADAP) Announces Initiation Of Study To Evaluate Its New Affinity Enhanced T-Cell Therapy Targeting MAGE-A10 In Patients With NSCLC, The Most Common Form Of Lung Cancer 12/17/2015 10:04:24 AM
Adaptimmune (ADAP) And Universal Cells Announce Collaboration To Develop Allogeneic T-Cell Therapies 12/1/2015 10:17:03 AM
Adaptimmune (ADAP) nitiates Phase I/II Trial Evaluating Its Affinity Enhanced T-Cell Therapy Targeting NY-ESO-1 In Patients With The Most Common Type Of Lung Cancer 11/25/2015 7:42:38 AM
Adaptimmune (ADAP) To Participate In The Jefferies Autumn 2015 Global Healthcare Conference 11/12/2015 11:30:58 AM
Adaptimmune (ADAP) Announces Data From Clinical Study Of NY-ESO Affinity Enhanced T-Cell Therapy In Synovial Sarcoma At The 2015 Annual Meeting Of The Society Of Immunotherapy For Cancer (SITC) 11/5/2015 12:06:07 PM
Adaptimmune (ADAP) Announces Upcoming Data Presentation At The 2015 Annual Meeting Of The Society Of Immunotherapy For Cancer (SITC) 10/30/2015 8:37:58 AM
Adaptimmune To Report Full Fiscal Year 2015 Financial Results On October 13, 2015 10/7/2015 7:31:58 AM
Adaptimmune to Build New R&D Facility in the U.K. 10/6/2015 7:38:48 AM